New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - estradiol hemihydrate 5.88mg equivalent to estradiol 5.69 mg (75µg/24h) - transdermal patch - 75 mcg/24h - active: estradiol hemihydrate 5.88mg equivalent to estradiol 5.69 mg (75µg/24h) excipient: acrylates copolymer ethyl oleate glyceryl monolaurate isopropyl myristate - for short-term treatment of complaints associated with the menopause and post-menopause, including signs and symptoms of oestrogen deficiency, whether naturally or surgically induced. oestrogen replacement therapy in women with an intact uterus should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. prevention of postmenopausal osteoporosis.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - acarbose 100mg - tablet - 100 mg - active: acarbose 100mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - glucobay is indicated for the additional treatment of insulin dependant and non-insulin dependant diabetes mellitus in association with diet.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - acarbose 50mg - tablet - 50 mg - active: acarbose 50mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - glucobay is indicated for the additional treatment of insulin dependant and non-insulin dependant diabetes mellitus in association with diet.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - iloprost trometamol 134 µg/ml equivalent to 100 µg iloprost/ml;  ;   - solution for infusion - 50 mcg/0.5ml - active: iloprost trometamol 134 µg/ml equivalent to 100 µg iloprost/ml     excipient: ethanol hydrochloric acid sodium chloride trometamol water for injection - treatment of patients with severe peripheral arterial occlusive disease (paod) particularly those at risk of amputation and in whom surgery or angioplasty is not possible.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - levonorgestrel 75mg (micronised) - subcutaneous implant - 150 mg - active: levonorgestrel 75mg (micronised) excipient: dow corning qcf-7-4910 dimethylsiloxane/methylvinylsiloxane external tubing (373-tw) polysiloxane adhesive type a - long-term contraception

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - vardenafil 10mg (as vardenafil hydrochloride trihydrate 11.852mg) - film coated tablet - 10 mg - active: vardenafil 10mg (as vardenafil hydrochloride trihydrate 11.852mg) excipient: colloidal silicon dioxide crospovidone hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose titanium dioxide

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - vardenafil 20mg (as vardenafil hydrochloride trihydrate 23.705mg) - film coated tablet - 20 mg - active: vardenafil 20mg (as vardenafil hydrochloride trihydrate 23.705mg) excipient: colloidal silicon dioxide crospovidone hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose titanium dioxide

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - vardenafil 5mg (as vardenafil hydrochloride trihydrate 5.926mg) - film coated tablet - 5 mg - active: vardenafil 5mg (as vardenafil hydrochloride trihydrate 5.926mg) excipient: colloidal silicon dioxide crospovidone hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose titanium dioxide

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - ethinylestradiol 30ug; levonorgestrel 150ug - tablet - active: ethinylestradiol 30ug levonorgestrel 150ug excipient: calcium carbonate glycerol glycol montanate iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose titanium dioxide calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose - oral contraception.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

bayer new zealand limited - meglumine gadopentetate 469 mg/ml (formed from gadolinium oxide, diethylenetriamine pentetic acid & meglumine) - solution for injection - 469 mg/ml - active: meglumine gadopentetate 469 mg/ml (formed from gadolinium oxide, diethylenetriamine pentetic acid & meglumine) excipient: meglumine pentetic acid water for injection